RNA-protein interaction study identifies new coronavirus drug targets

A study co-led by UC Riverside and UC San Diego has identified new antiviral drug targets for SARS-CoV-2 by mapping RNA-protein interactions. Researchers used the eCLIP technique to discover how viral proteins interact with RNA, revealing essential sites for replication and regulation.

Published in Nature Communications, the findings highlight interactions involving the RNA-dependent RNA polymerase and nucleocapsid proteins. By targeting these stable, essential viral components rather than rapidly evolving features like the spike protein, scientists aim to develop treatments less susceptible to drug resistance. This research provides a proof of concept for disrupting viral life cycles at fundamental machinery points.

Editor's note: Excellent summary of the research methodology and its implications for antiviral development.